| Description: |
circGFRA1 is a drug-responsive circRNA in breast cancer cell lines; in MDA-MB-231 it is decreased by AMG511 and GSK1070916, interpreted as an effective drug response. The paper cites that circGFRA1 binds miR-34a and is linked to proliferation/anti-apoptosis and poorer survival in triple-negative breast cancer, and proposes its downregulation as a biomarker of effective treatment. |